Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001645966-15-000001
Filing Date
2015-07-14
Accepted
2015-07-14 09:11:17
Documents
1
Effectiveness Date
2015-07-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5814
  Complete submission text file 0001645966-15-000001.txt   6838
Mailing Address 7805 PEMSWOOD STREET CHARLOTTE NC 28277
Business Address 7805 PEMSWOOD STREET CHARLOTTE NC 28277 704-807-6502
Ballantyne Therapeutics, Inc. (Filer) CIK: 0001645966 (see all company filings)

EIN.: 472125610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-243626 | Film No.: 15986564